QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2018    内容类型：会议论文    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A Multicentral Quality Assurance Study of Target Volume Delineation for A Prospective, Random, Multicenter Study: 3JECOG P-01 会议论文 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01 作者:  Chang, X.;  Xiao, Z.;  Wang, X.;  Tian, Y.;  Zhang, W. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Dose modification and therapy interruption due to adverse events in treatment with anlotinib for refractory advanced NSCLC: Data from ALTER0303 会议论文 ANNALS OF ONCOLOGY, 2018-10-01 作者:  Zhang, L.;  Si, X.;  Wang, H.;  Zhang, X.;  Wang, M. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 A Chinese Multi-Institutional Analysis of Three Dimensional Conformal Radiation or Intensity-Modulated Radiation Therapy for Non-Operated Localized Esophageal Squamous Cell Carcinoma in Definitive (Chemo) Radiation 会议论文 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01 作者:  Wang, X.;  Wang, L.;  Chen, J. Q.;  Zhang, W.;  Wang, X. M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文 ANNALS OF ONCOLOGY, 2018-11-01 作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) 会议论文 ANNALS OF ONCOLOGY, 2018-10-01 作者:  Crino, L.;  Ahn, M-J.;  Han, J-Y.;  Liu, X.;  Ou, S-H. I. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03